Kastelein JJ - Search Results

1

Differential leucocyte count and the risk of future coronary artery disease in healthy men and women: the EPIC-Norfolk Prospective Population Study.

Rana JS, Boekholdt SM, Ridker PM, Jukema JW, Luben R, Bingham SA, Day NE, Wareham NJ, Kastelein JJ, Khaw KT. Rana JS, et al. Among authors: kastelein jj. J Intern Med. 2007 Dec;262(6):678-89. doi: 10.1111/j.1365-2796.2007.01864.x. Epub 2007 Oct 1. J Intern Med. 2007. PMID: 17908163 Free article.

2

Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study.

Holleboom AG, Kuivenhoven JA, Vergeer M, Hovingh GK, van Miert JN, Wareham NJ, Kastelein JJ, Khaw KT, Boekholdt SM. Holleboom AG, et al. Among authors: kastelein jj. J Lipid Res. 2010 Feb;51(2):416-21. doi: 10.1194/P900038-JLR200. Epub 2009 Aug 11. J Lipid Res. 2010. PMID: 19671930 Free PMC article.

3

Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS).

Klerkx AH, de Grooth GJ, Zwinderman AH, Jukema JW, Kuivenhoven JA, Kastelein JJ. Klerkx AH, et al. Among authors: kastelein jj. Eur J Clin Invest. 2004 Jan;34(1):21-8. doi: 10.1111/j.1365-2362.2004.01281.x. Eur J Clin Invest. 2004. PMID: 14984434 Clinical Trial.

4

Lipoprotein (a) and risk of cardiovascular disease in patients with metabolic syndrome in a population of familial hypercholesterolaemia.

Rana JS, Jansen AC, Zwinderman AH, van Aalst-Cohen ES, Jukema JW, Trip MD, Kastelein JJ. Rana JS, et al. Among authors: kastelein jj. J Intern Med. 2006 Aug;260(2):183-5. doi: 10.1111/j.1365-2796.2006.01670.x. J Intern Med. 2006. PMID: 16882284 Free article. No abstract available.

5

Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.

Rana JS, Nieuwdorp M, Jukema JW, Kastelein JJ. Rana JS, et al. Among authors: kastelein jj. Diabetes Obes Metab. 2007 May;9(3):218-32. doi: 10.1111/j.1463-1326.2006.00594.x. Diabetes Obes Metab. 2007. PMID: 17391148 Review.

6

Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study.

Rana JS, Cote M, Després JP, Sandhu MS, Talmud PJ, Ninio E, Wareham NJ, Kastelein JJ, Zwinderman AH, Khaw KT, Boekholdt SM. Rana JS, et al. Among authors: kastelein jj. Heart. 2009 Oct;95(20):1682-7. doi: 10.1136/hrt.2009.170134. Epub 2009 Jul 8. Heart. 2009. PMID: 19587389 Free article.

7

Physical inactivity, abdominal obesity and risk of coronary heart disease in apparently healthy men and women.

Arsenault BJ, Rana JS, Lemieux I, Després JP, Kastelein JJ, Boekholdt SM, Wareham NJ, Khaw KT. Arsenault BJ, et al. Among authors: kastelein jj. Int J Obes (Lond). 2010 Feb;34(2):340-7. doi: 10.1038/ijo.2009.229. Epub 2009 Nov 17. Int J Obes (Lond). 2010. PMID: 19918249

8

Paraoxonase variants relate to 10-year risk in coronary artery disease: impact of a high-density lipoprotein-bound antioxidant in secondary prevention.

Regieli JJ, Jukema JW, Doevendans PA, Zwinderman AH, Kastelein JJ, Grobbee DE, van der Graaf Y. Regieli JJ, et al. Among authors: kastelein jj. J Am Coll Cardiol. 2009 Sep 29;54(14):1238-45. doi: 10.1016/j.jacc.2009.05.061. J Am Coll Cardiol. 2009. PMID: 19778663 Free article. Clinical Trial.

9

The role of a common variant of the cholesteryl ester transfer protein gene in the progression of coronary atherosclerosis. The Regression Growth Evaluation Statin Study Group.

Kuivenhoven JA, Jukema JW, Zwinderman AH, de Knijff P, McPherson R, Bruschke AV, Lie KI, Kastelein JJ. Kuivenhoven JA, et al. Among authors: kastelein jj. N Engl J Med. 1998 Jan 8;338(2):86-93. doi: 10.1056/NEJM199801083380203. N Engl J Med. 1998. PMID: 9420339 Free article. Clinical Trial.

10

The Asn9 variant of lipoprotein lipase is associated with the -93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group.

Kastelein JJ, Groenemeyer BE, Hallman DM, Henderson H, Reymer PW, Gagné SE, Jansen H, Seidell JC, Kromhout D, Jukema JW, Bruschke AV, Boerwinkle E, Hayden MR. Kastelein JJ, et al. Clin Genet. 1998 Jan;53(1):27-33. doi: 10.1034/j.1399-0004.1998.531530106.x. Clin Genet. 1998. PMID: 9550358

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

894 results

Search Page